FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/CTXR
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Citius Pharmaceuticals Inc (CTXR) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

CTXR trades at $0.4928, down 6.37% today, with a bullish technical signal from moving averages. The company reported its first revenue of $7.1 million in fiscal 2026 from LYMPHIR sales, though net losses persist. Analyst consensus is strongly positive with 83.3% buy ratings and a $5.00 price target, indicating significant upside potential from current levels.
The outlook hinges on commercial execution of LYMPHIR, with risks including high cash burn and competitive pressures. Near-term catalysts include investor conferences and ongoing commercial deployment. The stock offers high-risk, high-reward exposure to a nascent oncology product launch, with Wall Street optimism tempered by fundamental challenges.
Read full analysis

Key Stats

  • Market Cap
    $13.66M
  • Volume
    302,133
  • Sector
    Health
  • 52W High
    $1.44
  • 52W Low
    $0.37
  • Typical Hold Time
    19 Days
  • Enterprise Value
    $3.83M
  • Div Yield
    -
  • Trading Activity
    3% Sell | 97% Buy
$0.49
52W Low: $0.37
22 Oct 2026
52W High: $1.44
28 Nov 2025

Track Citius Pharmaceuticals Inc (CTXR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.37 and a high of $1.44, highlighting its annual price range. Buy and sell Citius Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Most Recent News

Content is generated by Aura AI

Investigation launched into Digital Turbine after financial report delay and restatement hit shares hard

Digital Turbine delayed its Q2 2027 financial results, then restated prior financials due to $3.5 million in understated revenue share expenses. This caused the stock to drop sharply, falling over 35% after the restatement. A law firm is investigatin...

Market News
3 hours ago
Kirby Mcinerney Llp
Bearish
news icon
Investigation launched into Digital Turbine after financial report delay and restatement hit shares hard

AtlasClear adds ninth correspondent, reports 85% revenue growth in fiscal 2026.

AtlasClear Holdings announced the signing of its ninth correspondent broker-dealer agreement through its subsidiary AtlasClearing, contributing to an 85% revenue increase to $20.1 million in fiscal 2026. This growth occurred before significant revenu...

Market News
3 hours ago
Na
Bullish
news icon
AtlasClear adds ninth correspondent, reports 85% revenue growth in fiscal 2026.

PIMCO High Income Fund yields 13.75% but faces income and valuation challenges amid inflation.

The PIMCO High Income Fund (PHK) offers a high yield of 13.75%, attracting income-focused investors. However, it struggles to cover its distributions from portfolio income due to significant speculative-grade exposure and persistent inflation pressur...

Market News
5 hours ago
Seeking Alpha
Bearish
news icon
PIMCO High Income Fund yields 13.75% but faces income and valuation challenges amid inflation.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $13.66M
  • Volume
    302,133
  • Sector
    Health
  • 52W High
    $1.44
  • 52W Low
    $0.37
  • Typical Hold Time
    19 Days
  • Enterprise Value
    $3.83M
  • Div Yield
    -
  • Trading Activity
    3% Sell | 97% Buy
$0.49
52W Low: $0.37
22 Oct 2026
52W High: $1.44
28 Nov 2025

Track Citius Pharmaceuticals Inc (CTXR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.37 and a high of $1.44, highlighting its annual price range. Buy and sell Citius Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!